Cargando…
iRGD‐modified exosomes effectively deliver CPT1A siRNA to colon cancer cells, reversing oxaliplatin resistance by regulating fatty acid oxidation
Fatty acid oxidation (FAO) plays a vital role in drug resistance in cancer cells. Carnitine palmitoyltransferase 1A (CPT1A), a key enzyme of FAO, is widely recognized as an emerging therapeutic target. Here, we confirmed that CPT1A was heterogeneously expressed in colon cancer cells, with a high exp...
Autores principales: | Lin, Dan, Zhang, Haiyang, Liu, Rui, Deng, Ting, Ning, Tao, Bai, Ming, Yang, Yuchong, Zhu, Kegan, Wang, Junyi, Duan, Jingjing, Ge, Shaohua, Sun, Bei, Ying, Guoguang, Ba, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637580/ https://www.ncbi.nlm.nih.gov/pubmed/34213835 http://dx.doi.org/10.1002/1878-0261.13052 |
Ejemplares similares
-
Corrigendum to: iRGD‐modified exosomes effectively deliver CPT1A siRNA to colon cancer cells, reversing oxaliplatin resistance by regulating fatty acid oxidation
Publicado: (2022) -
iRGD-modified exosomes-delivered BCL6 siRNA inhibit the progression of diffuse large B-cell lymphoma
por: Liu, Qinhua, et al.
Publicado: (2022) -
Exosomes serve as nanoparticles to suppress tumor growth and angiogenesis in gastric cancer by delivering hepatocyte growth factor siRNA
por: Zhang, Haiyang, et al.
Publicado: (2018) -
Exosome-Delivered c-Met siRNA Could Reverse Chemoresistance to Cisplatin in Gastric Cancer
por: Zhang, Qiumo, et al.
Publicado: (2020) -
Combined Self-Assembled iRGD Polymersomes for Effective Targeted siRNA Anti-Tumor Therapy
por: Li, Dongying, et al.
Publicado: (2022)